161 related articles for article (PubMed ID: 25808864)
21. TCR-ligand koff rate correlates with the protective capacity of antigen-specific CD8+ T cells for adoptive transfer.
Nauerth M; Weißbrich B; Knall R; Franz T; Dössinger G; Bet J; Paszkiewicz PJ; Pfeifer L; Bunse M; Uckert W; Holtappels R; Gillert-Marien D; Neuenhahn M; Krackhardt A; Reddehase MJ; Riddell SR; Busch DH
Sci Transl Med; 2013 Jul; 5(192):192ra87. PubMed ID: 23825303
[TBL] [Abstract][Full Text] [Related]
22. TCR-ligand dissociation rate is a robust and stable biomarker of CD8+ T cell potency.
Allard M; Couturaud B; Carretero-Iglesia L; Duong MN; Schmidt J; Monnot GC; Romero P; Speiser DE; Hebeisen M; Rufer N
JCI Insight; 2017 Jul; 2(14):. PubMed ID: 28724801
[TBL] [Abstract][Full Text] [Related]
23. Altered peptide ligands induce delayed CD8-T cell receptor interaction--a role for CD8 in distinguishing antigen quality.
Yachi PP; Ampudia J; Zal T; Gascoigne NR
Immunity; 2006 Aug; 25(2):203-11. PubMed ID: 16872849
[TBL] [Abstract][Full Text] [Related]
24. T-cell receptor triggering is critically dependent on the dimensions of its peptide-MHC ligand.
Choudhuri K; Wiseman D; Brown MH; Gould K; van der Merwe PA
Nature; 2005 Jul; 436(7050):578-82. PubMed ID: 16049493
[TBL] [Abstract][Full Text] [Related]
25. Loss of CTL function among high-avidity tumor-specific CD8+ T cells following tumor infiltration.
Janicki CN; Jenkinson SR; Williams NA; Morgan DJ
Cancer Res; 2008 Apr; 68(8):2993-3000. PubMed ID: 18413769
[TBL] [Abstract][Full Text] [Related]
26. Interplay between T cell receptor binding kinetics and the level of cognate peptide presented by major histocompatibility complexes governs CD8+ T cell responsiveness.
Irving M; Zoete V; Hebeisen M; Schmid D; Baumgartner P; Guillaume P; Romero P; Speiser D; Luescher I; Rufer N; Michielin O
J Biol Chem; 2012 Jun; 287(27):23068-78. PubMed ID: 22549784
[TBL] [Abstract][Full Text] [Related]
27. Generation of tumor antigen-specific murine CD8+ T cells with enhanced anti-tumor activity via highly efficient CRISPR/Cas9 genome editing.
Ouchi Y; Patil A; Tamura Y; Nishimasu H; Negishi A; Paul SK; Takemura N; Satoh T; Kimura Y; Kurachi M; Nureki O; Nakai K; Kiyono H; Uematsu S
Int Immunol; 2018 Apr; 30(4):141-154. PubMed ID: 29617862
[TBL] [Abstract][Full Text] [Related]
28. The abrogation of TCR-independent interactions with human serum ensures a selective capture of therapeutic virus-specific CD8+ T-cells by multimer technology in Adoptive Immunotherapy.
Beloki L; Ciáurriz M; Mansilla C; Bandrés E; Rodríguez-Calvillo M; Ramírez N; Olavarría E
J Immunol Methods; 2013 Oct; 396(1-2):168-72. PubMed ID: 23933324
[TBL] [Abstract][Full Text] [Related]
29. Loss of CD8 and TCR binding to Class I MHC ligands following T cell activation.
Kao C; Daniels MA; Jameson SC
Int Immunol; 2005 Dec; 17(12):1607-17. PubMed ID: 16263755
[TBL] [Abstract][Full Text] [Related]
30. Extent of MHC Clustering Regulates Selectivity and Effectiveness of T Cell Responses.
Anikeeva N; Fischer NO; Blanchette CD; Sykulev Y
J Immunol; 2019 Jan; 202(2):591-597. PubMed ID: 30541879
[TBL] [Abstract][Full Text] [Related]
31. [MHC tetramers: tracking specific immunity].
Kosor E; Gagro A; Drazenović V; Kuzman I; Jeren T; Rakusić S; Rabatić S; Markotić A; Gotovac K; Sabioncello A; Cecuk E; Kerhin-Brkljacić V; Gjenero-Margan I; Kaić B; Mlinarić-Galinović G; Kastelan A; Dekaris D
Acta Med Croatica; 2003; 57(4):255-9. PubMed ID: 14639858
[TBL] [Abstract][Full Text] [Related]
32. Normalized Synergy Predicts That CD8 Co-Receptor Contribution to T Cell Receptor (TCR) and pMHC Binding Decreases As TCR Affinity Increases in Human Viral-Specific T Cells.
Williams CM; Schonnesen AA; Zhang SQ; Ma KY; He C; Yamamoto T; Eckhardt SG; Klebanoff CA; Jiang N
Front Immunol; 2017; 8():894. PubMed ID: 28804489
[TBL] [Abstract][Full Text] [Related]
33. The efficiency of antigen recognition by CD8+ CTL clones is determined by the frequency of serial TCR engagement.
Hudrisier D; Kessler B; Valitutti S; Horvath C; Cerottini JC; Luescher IF
J Immunol; 1998 Jul; 161(2):553-62. PubMed ID: 9670927
[TBL] [Abstract][Full Text] [Related]
34. Evidence for a TCR affinity threshold delimiting maximal CD8 T cell function.
Schmid DA; Irving MB; Posevitz V; Hebeisen M; Posevitz-Fejfar A; Sarria JC; Gomez-Eerland R; Thome M; Schumacher TN; Romero P; Speiser DE; Zoete V; Michielin O; Rufer N
J Immunol; 2010 May; 184(9):4936-46. PubMed ID: 20351194
[TBL] [Abstract][Full Text] [Related]
35. Selection of high-avidity CD8 T cells correlates with control of hepatitis C virus infection.
Neveu B; Debeaupuis E; Echasserieau K; le Moullac-Vaidye B; Gassin M; Jegou L; Decalf J; Albert M; Ferry N; Gournay J; Houssaint E; Bonneville M; Saulquin X
Hepatology; 2008 Sep; 48(3):713-22. PubMed ID: 18712791
[TBL] [Abstract][Full Text] [Related]
36. Blood dendritic cells generated with Flt3 ligand and CD40 ligand prime CD8+ T cells efficiently in cancer patients.
Davis ID; Chen Q; Morris L; Quirk J; Stanley M; Tavarnesi ML; Parente P; Cavicchiolo T; Hopkins W; Jackson H; Dimopoulos N; Tai TY; MacGregor D; Browning J; Svobodova S; Caron D; Maraskovsky E; Old LJ; Chen W; Cebon J
J Immunother; 2006; 29(5):499-511. PubMed ID: 16971806
[TBL] [Abstract][Full Text] [Related]
37. Low binding capacity of murine tetramers mutated at residue 227 does not preclude the ability to efficiently activate CD8+ T lymphocytes.
Nugent CT; Renteria RO; Kuus-Reichel K; Kumar A
Immunol Lett; 2005 May; 98(2):208-15. PubMed ID: 15860220
[TBL] [Abstract][Full Text] [Related]
38. Preparation of peptide-MHC and T-cell receptor dextramers by biotinylated dextran doping.
Bethune MT; Comin-Anduix B; Hwang Fu YH; Ribas A; Baltimore D
Biotechniques; 2017 Mar; 62(3):123-130. PubMed ID: 28298179
[TBL] [Abstract][Full Text] [Related]
39. Peptide-MHC Class I Tetramers Can Fail To Detect Relevant Functional T Cell Clonotypes and Underestimate Antigen-Reactive T Cell Populations.
Rius C; Attaf M; Tungatt K; Bianchi V; Legut M; Bovay A; Donia M; Thor Straten P; Peakman M; Svane IM; Ott S; Connor T; Szomolay B; Dolton G; Sewell AK
J Immunol; 2018 Apr; 200(7):2263-2279. PubMed ID: 29483360
[TBL] [Abstract][Full Text] [Related]
40. Neoantigen-specific CD8 T cells with high structural avidity preferentially reside in and eliminate tumors.
Schmidt J; Chiffelle J; Perez MAS; Magnin M; Bobisse S; Arnaud M; Genolet R; Cesbron J; Barras D; Navarro Rodrigo B; Benedetti F; Michel A; Queiroz L; Baumgaertner P; Guillaume P; Hebeisen M; Michielin O; Nguyen-Ngoc T; Huber F; Irving M; Tissot-Renaud S; Stevenson BJ; Rusakiewicz S; Dangaj Laniti D; Bassani-Sternberg M; Rufer N; Gfeller D; Kandalaft LE; Speiser DE; Zoete V; Coukos G; Harari A
Nat Commun; 2023 Jun; 14(1):3188. PubMed ID: 37280206
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
